{
  "context": {
    "rules": [
      "Rule1: If the researcher follows the safety protocol, then under the condition that the drug company does not test the final product, it is not the case that the drug company releases a defective product.",
      "Rule2: Either the researcher follows the safety protocol or the drug company implements quality control.",
      "Rule3: When the manufacturing process requires sterile equipment, then either the scientist discovers a new compound or, provided that the drug company implements quality control, if the drug company does not test the final product, then it is not the case that the drug company releases a defective product.",
      "Rule4: Provided that the technician detects contamination, then if the quality inspector halts the manufacturing process, the production line contaminates with bacteria.",
      "Rule5: Either the technician detects contamination or the lab technician observes an impurity.",
      "Rule6: If the drug company uses laboratory tools, then either the drug company develops a new vaccine or the drug company produces an effective medicine.",
      "Rule7: Whenever the drug company maintains the clean room, then either the drug company purifies the active ingredient or the drug company modifies the chemical structure.",
      "Rule8: Either the drug company maintains the clean room or the technician sterilizes the equipment.",
      "Rule9: Either the researcher develops an alternative method or, if the technician sterilizes the equipment, then either the drug company purifies the active ingredient or the drug company modifies the chemical structure.",
      "Rule10: If the drug company manufactures the active ingredient, then the drug company uses laboratory tools.",
      "Rule11: Provided that the drug company synthesizes a chemical compound, then the drug company uses laboratory tools.",
      "Rule12: If the drug company purifies the active ingredient, then the drug company manufactures the active ingredient.",
      "Rule13: Under the condition that the drug company modifies the chemical structure, then the drug company synthesizes a chemical compound.",
      "Rule14: Whenever the drug company tests the final product, then either the drug company purifies the active ingredient or the drug company modifies the chemical structure.",
      "Rule15: If the researcher documents the analysis procedure, then either the drug company analyzes test results or the drug company tests the final product.",
      "Rule16: If it is not the case that when the lab technician observes an impurity, then if the quality inspector halts the manufacturing process, the production line contaminates with bacteria, then the drug company resumes manufacturing.",
      "Rule17: Under the condition that it is not the case that if the lab technician observes an impurity, then when the quality inspector halts the manufacturing process, the production line contaminates with bacteria, then it is not the case that the drug company resumes manufacturing.",
      "Rule18: Provided that the manufacturing process does not require sterile equipment, then the quality inspector halts the manufacturing process.",
      "Rule19: If the drug company does not test the final product, then the drug company releases a defective product."
    ],
    "facts": [
      "Fact1: The researcher documents the analysis procedure.",
      "Fact2: It is not the case that the drug company develops a new vaccine.",
      "Fact3: The scientist does not discover a new compound.",
      "Fact4: The production line does not contaminate with bacteria.",
      "Fact5: The researcher does not develop an alternative method.",
      "Fact6: It is not the case that the drug company analyzes test results."
    ]
  },
  "question": "The drug company produces an effective medicine."
}